Alnylam Pharmaceuticals | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Moderna USD 10.9B 1.03B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 729M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Takeda JPY 7.42T 497.52B 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 677.61M 46.22M 2024-12



Alnylam Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.